A Double-Blind, Placebo-Controlled, Multiple Crossover Proof-of-Concept Study to Evaluate the Efficacy of CHADD (Controlled Heat-Assisted Drug Delivery) Applied Over a ZR-02-01 Matrix Transdermal Fentanyl Patch for the Treatment of Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Chronic Pain
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2012
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors ZARS Pharma
- 04 Jun 2012 Additional lead trial investigator (Lynn R Webster) identified as reported by ClinicalTrials.gov.
- 04 Jun 2012 Actual end date (Aug 2006) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.